Literature DB >> 1898373

Levels of ornithine decarboxylase genomic sequences, heterogeneous nuclear RNA and mRNA in human myeloma cells resistant to alpha-difluoromethylornithine.

I M Hyttinen1, M Halmekytö, L Alhonen, J Jänne.   

Abstract

We previously isolated and characterized a human myeloma cell line overproducing ornithine decarboxylase (ODC) due to gene amplification [Leinonen, Alhonen-Hongisto, Laine, Jänne & Jänne (1987) Biochem. J. 242, 199-203]. We have now employed the PCR combined with reverse transcription to determine semiquantitatively ODC gene dosage and the amounts of heterogeneous nuclear (hn) RNA and of mature mRNA of the enzyme in parental and alpha-difluoromethylornithine-resistant human myeloma cells. Experiments with dilution series revealed that the ODC gene copy number and the amount of both hnRNA and mRNA were increased to the same extent (about 100-fold) in the resistant cells. Similar dot-blot analyses of ODC-specific genomic DNA and total RNA indicated that the ODC gene copy number was increased by a factor of 380 and the amount of ODC mRNA by a factor of 700. Our results indicate that the PCR combined with reverse transcription is at least as useful as blot analyses to give semiquantitative assessment of the amounts of specific DNA or RNA sequences. In addition, the use of the PCR enables the analysis of minute sample amounts in extremely short time.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1898373      PMCID: PMC1151427          DOI: 10.1042/bj2780871

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  15 in total

1.  Quantitative measurement of mRNAs by polymerase chain reaction.

Authors:  B C Delidow; J J Peluso; B A White
Journal:  Gene Anal Tech       Date:  1989 Nov-Dec

2.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

3.  Transcriptional activity of the human thymidine kinase gene determined by a method using the polymerase chain reaction and an intron-specific probe.

Authors:  K E Lipson; R Baserga
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

4.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

5.  Human ornithine decarboxylase-encoding loci: nucleotide sequence of the expressed gene and characterization of a pseudogene.

Authors:  N J Hickok; J Wahlfors; A Crozat; M Halmekytö; L Alhonen; J Jänne; O A Jänne
Journal:  Gene       Date:  1990-09-14       Impact factor: 3.688

6.  Multiple mechanisms are responsible for altered expression of ornithine decarboxylase in overproducing variant cells.

Authors:  L McConlogue; S L Dana; P Coffino
Journal:  Mol Cell Biol       Date:  1986-08       Impact factor: 4.272

7.  Human myeloma cells acquire resistance to difluoromethylornithine by amplification of ornithine decarboxylase gene.

Authors:  P Leinonen; L Alhonen-Hongisto; R Laine; O A Jänne; J Jänne
Journal:  Biochem J       Date:  1987-02-15       Impact factor: 3.857

8.  Human myeloma cells acquire resistance to difluoromethylornithine without overproducing ornithine decarboxylase.

Authors:  L Alhonen-Hongisto; P Leinonen; R Laine; J Jänne
Journal:  Biochem Biophys Res Commun       Date:  1987-04-14       Impact factor: 3.575

9.  Characterization of difluoromethylornithine-resistant mouse and human tumour cell lines.

Authors:  A Hirvonen; T Eloranta; T Hyvönen; L Alhonen; J Jänne
Journal:  Biochem J       Date:  1989-03-15       Impact factor: 3.857

10.  Rearrangement between ornithine decarboxylase and the switch region of the gamma 1 immunoglobulin gene in alpha-difluoromethylornithine resistant mouse myeloma cells.

Authors:  A Katz; C Kahana
Journal:  EMBO J       Date:  1989-04       Impact factor: 11.598

View more
  7 in total

1.  Inhibition of the expression of ornithine decarboxylase and c-Myc by cell-permeant ceramide in difluoromethylornithine-resistant leukaemia cells.

Authors:  F Flamigni; I Faenza; S Marmiroli; I Stanic'; A Giaccari; C Muscari; C Stefanelli; C Rossoni
Journal:  Biochem J       Date:  1997-06-15       Impact factor: 3.857

2.  The role of polyamines in gastric mucus synthesis inhibited by cigarette smoke or its extract.

Authors:  L Ma; W P Wang; J Y Chow; S K Lam; C H Cho
Journal:  Gut       Date:  2000-08       Impact factor: 23.059

3.  Certain changes in ornithine decarboxylase gene methylation accompany gene amplification.

Authors:  J Wahlfors
Journal:  Biochem J       Date:  1991-10-15       Impact factor: 3.857

4.  Long-term reduction of amplified ornithine decarboxylase sequences in human myeloma cells.

Authors:  J Wahlfors; S Myöhänen; V P Korhonen; L Alhonen; J Jänne
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

5.  Regulation of the expression of human ornithine decarboxylase gene and ornithine decarboxylase promoter-driven reporter gene in transgenic mice.

Authors:  M Halmekytö; J M Hyttinen; R Sinervirta; P Leppänen; J Jänne; L Alhonen
Journal:  Biochem J       Date:  1993-06-15       Impact factor: 3.857

6.  Characterization of a transgenic mouse line over-expressing the human ornithine decarboxylase gene.

Authors:  M Halmekytö; L Alhonen; J Wahlfors; R Sinervirta; T Eloranta; J Jänne
Journal:  Biochem J       Date:  1991-09-15       Impact factor: 3.857

7.  Modulation of the induction of ornithine decarboxylase by some opioid receptor agonists in immune cells and cardiomyocytes.

Authors:  C Pignatti; I Stanic; C Stefanelli; B Tantini; C Rossoni; F Flamigni
Journal:  Mol Cell Biochem       Date:  1998-08       Impact factor: 3.396

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.